Princeton Professor Launches Epicutis, a Professional Luxury Medical-Grade Skincare Line apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Willow Biosciences Inc. (
Willow or the
Company ) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed a series of studies with its development partner, Signum Biosciences, Inc., that demonstrate the safety and anti-inflammatory, anti-aging, and antimicrobial properties of Willow s cannabigerol (
Willow
CBG ). The studies demonstrate that Willow CBG is safe when applied to skin and eye areas and can act as a more potent antioxidant and anti-inflammatory for certain skin applications when compared to plant derived cannabidiol (
CBD ), as further described below. Demonstrating the safety and benefit of a new ingredient like Willow s CBG is a critical step in commercialization and it s one that we take seriously at the Company, said Dr. Chris Savile, Willow s Chief Operating Officer. Willow s CBG is now clinically tested to be safe for sensitive skin and demonstrated in the laboratory to act as a potent antioxidant, anti-inflammatory and anti-micro